News

11.12.2023

EU funds research into causes and new therapies for multiple sclerosis

The progression of multiple sclerosis (MS) can usually be slowed down with medication, but a cure is currently not possible….

People with multiple sclerosis and neurological disorders demand Europe-wide actions to ensure quality access to care

04.12.2023

Today, the European Multiple Sclerosis Platform, which brings together 43 MS societies from 37 European countries, launched its European elections…

EMSP @ ECTRIMS 2023 – Key takeaways

26.10.2023

Introduction EMSP at ECTRIMS 2023 Highlights of sessions attended by EMSP delegates Plenary session Epstein-Barr virus (EBV) and MS Transition…

22.09.2023

Ground-breaking research with potential for MS treatments launched

Targeting Epstein-Barr virus to treat and prevent MS Researchers launch pioneering EU funded research initiative to uncover role of Epstein-Barr…

EMSP’s reaction to the State of the European Union 2023: we need a Health Union which enhances opportunities for people with MS

13.09.2023

On 13 September, Ursula van der Leyen President of the European Commission, has delivered her annual State of the European…

EMSP welcomes new Communications and Membership Coordinator

07.09.2023

In July 2023, we said good bye to Máté Tagaj László, Senior Communications and Membership Coordinator, who worked with us…

24.07.2023

Impact of Multiple Sclerosis Symptoms (IMSS) – Where are we now and what can you do?

EMSP and 25 member organisations have launched their pan-European survey on the Impact of Multiple Sclerosis Symptoms (IMSS) in May…

Equipped for Impact: MS CAB Members Successfully Completed Training Program

29.06.2023

We are thrilled to share some exciting news from the Multiple Sclerosis Community Advisory Board (MSCAB) facilitated by Rob Camp…

EMSP YPN at EYE 2023

29.06.2023

On the exciting days of June 9th and 10th of 2023, the Young People’s Network of EMSP embarked on an…

1 2 3 4 27